Autopsy report · NCT01874730

KOREAN Enhanced RecOvery Strategy for Colorectal Surgery

“Very slow accrual because sites have few open colorectal surgery”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 11 months before it stopped.
• 101 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Duke University

Sponsor type

University, hospital or other

Conditions

Goal-oriented Fluid Therapy; Colorectal Surgery

Interventions

Combined epidural-general anesthesia (CEGA); Volulyte® (6% HES 130/0.4 in balanced solution); Patient-Controlled Epidural Analgesia (PCEA)

Participants

101

Sites

3

Countries

South Korea

Trials that died the same way

• Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
  “Due to slow accrual of patients” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.